samedan logo

home > news > detailed info

PRISYM ID announces six further projects go live as medical device and life science organizations prepare for the future


Labeling software firm has implemented six new software systems in the last few months in a sign that the market is now rebalancing after the upheavals of the last 12 months. It says customers within medical device and life science sectors are increasing

Wokingham, United Kingdom 25 May 2021 Following its announcement of five significant business wins at the start of the year, PRISYM ID has said that it has successfully implemented a further six new regulated labeling software systems as demand from across the medical device and life science sectors increases.

The market leading labeling software firm says that this strong performance demonstrates the medical device and life science industries are recovering from the impact of the pandemic and are refocusing on implementing labeling management solutions to help prepare for the future.

The company adds that it sees the experience of the pandemic having an impact on the market as customers look for solutions that will increase their flexibility and allow them to respond more effectively to any change or uncertainty in their business over the months ahead.

In particular, many organizations are prioritizing speed of implementation as they seek to implement solutions that can help them as they prepare for life post pandemic – as a result, PRISYM ID says that its customers are putting a far greater focus on so-called “time to value” for their technology investments than ever before.

Richard Adams, Chief Executive of PRISYM ID, said: “We are incredibly pleased to have delivered PRISYM 360 solutions across both our medical device and clinical trial supply sectors. The first few months of 2021 have been extremely busy for us as it is clear that the legacy of COVID-19 has focused people’s minds. “For our customers, fast and agile implementation combined with specialist industry knowledge are extremely important, and the projects we have successfully executed in recent months show we can deliver the best of all worlds: high quality solutions, delivered at speed, by genuine experts in the field.”
phone +44 (0) 118 936 4400
email TECH House, Oaklands Business Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FD, UK
Print this page
Send to a friend
News and Press Releases

Sysmex Launches New Products for the Haemostasis Field in the EMEA Region: Automated Blood Coagulation Analysers CN-3500 and CN-6500 Using Chemiluminescence Enzyme Immunoassay (CLEIA) Technology to Enhance the Testing Workflow

Norderstedt, Germany, 13 July 2021 – Sysmex Europe GmbH announces the launch of new products for the haemostasis field in specific designated countries of the EMEA region: the automated blood coagulation analysers CN-3500 and CN-6500, targeted at medium- and large-scale hospitals and commercial labs, as well as other facilities.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement